CELEX: 62014CA0567
Language: en
Date: 2016-07-07 00:00:00
Title: Case C-567/14: Judgment of the Court (First Chamber) of 7 July 2016 (request for a preliminary ruling from the Cour d’appel de Paris — France) — Genentech Inc. v Hoechst GmbH, Sanofi-Aventis Deutschland GmbH (Reference for a preliminary ruling — Competition — Article 101 TFEU — Non-exclusive licence agreement — Patent — No infringement — Obligation to pay royalties)

12.9.2016   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 335/8
            
         Judgment of the Court (First Chamber) of 7 July 2016 (request for a preliminary ruling from the Cour d’appel de Paris — France) — Genentech Inc. v Hoechst GmbH, Sanofi-Aventis Deutschland GmbH
   (Case C-567/14) (1)
   
   ((Reference for a preliminary ruling - Competition - Article 101 TFEU - Non-exclusive licence agreement - Patent - No infringement - Obligation to pay royalties))
   (2016/C 335/09)
   Language of the case: French
   
      Referring court
   
   Cour d’appel de Paris
   
      Parties to the main proceedings
   
   
      Applicant: Genentech Inc.
   
      Defendants: Hoechst GmbH, Sanofi-Aventis Deutschland GmbH
   
      Operative part of the judgment
   
   Article 101(1) TFEU must be interpreted as not precluding the imposition on the licensee, under a licence agreement such as that at issue in the main proceedings, of a requirement to pay a royalty for the use of a patented technology for the entire period in which that agreement was in effect, in the event of the revocation or non-infringement of a licensed patent, provided that the licensee was able freely to terminate that agreement by giving reasonable notice.
   
      (1)  OJ C 73, 2.3.2015.